Kidney dysfunction contributes to severe malaria

March 29, 2018

Understanding the most severe presentations of malaria is key to lowering the mortality associated with the infectious disease, which currently stands around 500,000 deaths a year. Researchers have now reinforced the idea that kidney dysfunction is a contributing factor to severe Plasmodium vivax malaria cases. The results of their new study appear in PLOS Neglected Tropical Diseases.

Malaria, caused by a handful of Plasmodium parasites and spread by mosquitos in tropical and subtropical areas of the world, affects over 200 million people a year. Historically, P. vivax has been associated with more mild presentations of disease, with P. falciparum causing increased severity and mortality. However, severe cases of P. vivax have been more frequently reported in recent years. These cases are often associated with impaired immune response, inflammation, and kidney involvement.

In the new work, Bruno Andrade of the Oswaldo Cruz Foundation in Brazil, and colleagues analyzed data on 572 individuals from the Brazilian Amazon, including 179 patients with P. vivax infection--18 of whom had severe disease--and 165 healthy controls. The researchers studied levels of creatinine, a marker of kidney function, as well as markers of inflammation, and followed the course of disease in the patients.

Severity of disease was associated with abnormal creatinine increases, and patients who died from severe disease had the highest levels of creatinine. In addition, the levels of several immune molecules-- including IFN-γ/IL-10 ratios and CRP values--could predict outcome in subjects with elevated creatinine, differentiating those who died. The results suggest that severe disease from P. vivax is associated with creatinine elevation and exacerbated inflammation.

"We predict that the systemic inflammation observed in more severely ill malaria patients could be contributing to kidney dysfunction through different mechanisms," the researchers say. "The identification of key factors driving the pathogenesis of this type of disease presentation and experimental models still are necessary to guide future studies and approaches."
-end-
FUNDING:

This work was supported by Financiadora de Estudos e Projetos (FINEP) (grant ward number: 010409605)/ Fundo Nacional de Desenvolvimento Científico e Tecnológico (FNDCT- CT-Amazonia). MB-N is a senior investigator from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil. L.A.B.C. received a fellowship from CNPq (154872/2017-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

COMPETING INTERESTS:

The authors declare that they have no competing interests.

PLOS

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.